CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 110 enrolled
Drug / intervention
botulinum toxin Type Adrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01608659
NCT01608659N/ACompleted
CompareCT.gov

An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A

Allergan·observational·Posted May 31, 2012·Updated Apr 17, 2019

In Brief

An observational study evaluating botulinum toxin Type A for Facial Rhytides. Completed, enrolled 110 participants across 1 site.

Detailed Summary

This is a retrospective chart review to evaluate treatment patterns of botulinum toxin Type A for the treatment of facial lines.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsFacial Rhytides
CountriesArgentina
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 31, 2012
Enrollment StartApr 1, 2011
Primary CompletionJun 17, 2011
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 14.1 years ago

Interventions

botulinum toxin Type Adrug

Previous treatment with botulinum toxin Type A for treatment of facial lines